WZ-WundZentren

What WZ-WundZentren does

WZ-WundZentren GmbH is a German healthcare service provider specializing in outpatient treatment of chronic and difficult-to-heal wounds, including Ulcus cruris (open leg), Dekubitus (pressure ulcers), diabetic foot syndrome, and acne inversa. Founded in 2008 and headquartered in Düsseldorf, the company operates a network of 22 to 24 certified WZ-WundZentrum locations across five German federal states (Baden-Württemberg, Bayern, Hessen, Nordrhein-Westfalen, Rheinland-Pfalz). Each center is staffed by WZ-WundManager-certified nursing specialists who deliver comprehensive wound assessment, cause diagnostics, individualized treatment, patient education, and coordination with treating specialist physicians (surgeons, vascular surgeons, dermatologists, diabetologists). More than 50,000 patients have been treated since inception, with average wound closure achieved in under four months for most patients after an average prior 12-month suffering period.

The company's core technology is clinical rather than software: standardized wound care protocols, highest hygiene infrastructure, interdisciplinary physician-nursing teams, and at select locations (Spilburg and Ulm) LAight light-based therapy for acne inversa. The business model is reimbursement-driven under the German statutory health insurance framework: WZ-WundZentren are legally recognized as specialized care facilities under the 2017 HHVG (§ 37 Abs. 7 SGB V, § 132a Abs. 4 SGB V) and are contracted partners of all statutory health insurance funds, with services billed on the basis of home nursing care. A specific strategic partnership with AOK-Baden-Württemberg, effective April 2023, deepened payer relationships and was followed by all substitute funds signing contracts in May 2023.

WZ-WundZentren GmbH is wholly owned by recucare GmbH, a diversified German healthcare group. The company is led by managing directors André Lantin and Frauke Lantin (founders) together with Daniela Bopp. There is no public listing and no disclosed external institutional or private-equity ownership. Growth is primarily organic, executed through new center openings (Potsdam and Hamburg-Bergedorf in 2022, Spilburg in 2023, Warendorf in 2024) and broadening payer and physician referral networks.

Name

WZ-WundZentren

Legal name

WZ-WundZentren GmbH

Website

https://wundzentren.de

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

WZ-WundZentren GmbH is a Düsseldorf-based, privately held German healthcare provider operating 22-24 specialized outpatient wound care centers across five federal states, treating chronic and difficult-to-heal wounds under statutory health insurance contracts.

Ownership category

akta.pro rank

Product category

Ambulatory Wound Care Services

NAICS

Other Ambulatory Health Care Services (6219), All Other Outpatient Care Centers (621498), Ambulatory Health Care Services (621), Home Health Care Services (62161)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082)

akta.pro primary industry

Ambulatory Wound Care & Hyperbaric Oxygen Therapy Centers (HLAFABAG)

akta.pro secondary industries

Wound, Ostomy & Continence Care (WOC) at Home (HSABACAE), Home-Based Wound Care & Ostomy Nursing (HLADAFAH)

Keywords

• Ambulatory wound care
• Chronic wound treatment
• Specialized nursing services
• Wound management services
• Outpatient wound therapy

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices26 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Ambulatory wound care services billed through health insurance: Services are billed through § 37 Abs. 7 SGB V on the basis of home nursing care (häusliche Krankenpflege). The company is a contracted provider (Vertragspartner) of all statutory health insurance funds. Patients with statutory insurance have a coverage claim (Versorgungsanspruch) for specialized wound treatment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

WZ-WundZentren GmbH operates a network of specialized outpatient nursing facilities providing ambulatory treatment of chronic and difficult-to-heal wounds, including Ulcus cruris, Dekubitus (pressure ulcers), diabetic foot syndrome, and acne inversa. Treatment is delivered by certified WZ-WundManager wound care nurses in cooperation with referring specialist physicians, with services reimbursed through all statutory German health insurance funds.

Product overview

WZ-WundZentren operates a network of specialized outpatient nursing facilities for the treatment of chronic and poorly healing wounds. The core offering is wound treatment services provided by certified WZ-WundManager nursing specialists at 22+ locations across 5 German states. The service portfolio includes specialized wound treatment for conditions such as Ulcus cruris, Dekubitus, diabetic foot syndrome, and acne inversa, with complementary offerings such as lAight light therapy for acne inversa treatment. WZ-WundZentren is registered as an ambulatory nursing facility under §132a Abs. 4 SGB V and is a contracted partner of all health insurance providers. The WZ-Praxisassistenz and WZ-WundManager personnel support facility operations and patient care. Patient education resources including the Wundlexikon are also provided.

Differentiator

Problem solved

Functional benefit

Products and services

• WZ-WundZentren Wundbehandlung (Specialized Outpatient Wound Treatment) Specialized outpatient treatment of chronic and difficult-to-heal wounds including Ulcus cruris (open leg), Dekubitus (pressure ulcers), diabetic foot syndrome, and other wound types. Services include comprehensive nursing assessment, cause research and diagnostics, counseling, individualized treatment, dressing changes, patient education, and coordination with treating physicians. Delivered by certified WZ-WundManager nursing specialists at 22 WZ-WundZentrum locations across Germany.
• LAight-Therapie (Light-Based Therapy for Acne Inversa) Light-based therapy for the treatment of acne inversa (hidradenitis suppurativa) and other forms of acne. Available at WZ-WundZentrum Spilburg (Wetzlar) and WZ-WundZentrum Ulm as a complement to the chronic wound care service portfolio, accessed via the dedicated WZ-LAight hotline.

Quantifiable outcome

• More than 50,000 patients treated successfully since 2008
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core.

• AOK-Baden-WürttembergcoreStrategic or Co-development Partner · 1 April 2023Contract partnership with AOK-Baden-Württemberg for specialized wound care services. Since April 2023, insured persons with chronic and difficult-to-heal wounds can access WZ-WundZentren services. Partnership covers multiple locations (Ulm, Freiburg, Heidelberg, Schramberg). All substitute health insurance funds have also signed contracts since May 2023.
• recucare GmbHcoreOthersWZ-WundZentren GmbH is a company of the recucare Gruppe. The parent company provides corporate services and infrastructure for the WZ-WundZentren network.
• All statutory health insurance funds (Alle Krankenkassen)coreStrategic or Co-development PartnerWZ-WundZentren are contracted partners of all statutory health insurance funds. Services are billed through § 37 Abs. 7 SGB V on the basis of home nursing care. Every insured person has a coverage claim for specialized wound treatment.
• Dr. med. Gregor Cammerer (Facharzt für Chirurgie, Viszeralchirurgie)coreStrategic or Co-development PartnerMedical cooperation partner at WZ-WundZentrum Ulm since summer 2021. Specialist for surgery, visceral surgery, special visceral surgery, and drug tumor therapy.
• Fachärzte (Specialist physicians)coreStrategic or Co-development PartnerWZ-WundZentren work closely with specialist physicians including surgeons, vascular surgeons, dermatologists, and diabetologists who provide medical supervision and referrals. Interdisciplinary teams consisting of physicians, nursing staff, and other healthcare providers.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Others

• Smith+Nephew: Global medical technology company with a sizable advanced wound management franchise. Adjacent peer serving the same chronic wound patient population through products used in clinics like WZ-WundZentren.
• Coloplast: Danish medical device company with a leading wound care and ostomy business. Adjacent peer as a strategic supplier and category benchmark for specialized wound-care economics.
• Convatec: Global medical device company focused on advanced wound care, ostomy, and continence products. Adjacent peer as a major supplier into the chronic wound ecosystem and a reference point for wound-care category economics.
• Mölnlycke Health Care: Swedish medtech firm specializing in wound care and surgical solutions. Adjacent peer whose products are used in chronic wound treatment settings comparable to WZ-WundZentren's clinics.
• recucare GmbH: Parent company and corporate group of WZ-WundZentren GmbH, providing shared infrastructure and services. Relevant as the strategic and capital backer that enables WZ-WundZentren's multi-site operating model.

Broad incumbents

• Schön Klinik: German hospital group specializing in orthopedics, neurology, and post-acute rehabilitation, including wound and post-surgical care. Comparable as a specialized, quality-driven German care operator with similar payor contracting dynamics.
• Sana Kliniken: Major German private hospital group with a growing outpatient and post-acute footprint. Comparable as a multi-site German healthcare provider; its ambulatory services overlap with WZ-WundZentren's referral-and-clinic model.
• Asklepios Kliniken: One of Germany's largest private hospital groups, operating broad inpatient and outpatient services including chronic wound management. Comparable as an established German healthcare provider with overlapping ambulatory care delivery, though wound care is a small part of its portfolio.
• Helios Health (Fresenius): Europe's largest hospital operator and part of Fresenius, delivering inpatient and outpatient care across Germany including post-acute and chronic disease services. Overlaps with WZ-WundZentren's ambulatory care positioning but on a much larger, diversified scale.

Emerging players

• MVZ-Medizinische Versorgungszentren (multi-site ambulatory clinic operators): German multi-site MVZ (medical care center) networks operate accredited ambulatory facilities with statutory payor contracts and physician referrals—the same operating chassis WZ-WundZentren uses. Comparable as ambulatory specialty clinic operators; few focus exclusively on chronic wound care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Wundzentrum
• LinkedInlinkedin.com/company/wz-wundzentren
• Instagraminstagram.com/wz_wundzentren

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WZ-WundZentren